Thermo Fisher counters tariffs with $2bn investment into US manufacturing
Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at its US sites.
Drug Manufacturers
3 reasons why biotechs preparing for launch need a compliant content foundation
Novartis commits $23bn to US manufacturing amid tariff threats
China’s NMPA authorises Santen’s glaucoma treatment application
J&J boosts US operations with $55bn investment
Are European biopharma manufacturers ‘nearshoring’?
Driving bioscience innovation: How Teesside University empowers industry breakthroughs
Radiopharmaceutical deals drive sector growth despite supply crisis
